Loading clinical trials...

GAPP 1 Survey: Global Attitudes of Patients and Physicians in Insulin Therapy for Diabetes Mellitus | Clinical Trials | Clareo Health

COMPLETED

GAPP 1 Survey: Global Attitudes of Patients and Physicians in Insulin Therapy for Diabetes Mellitus

NCT01950650•Novo Nordisk A/S

View on ClinicalTrials.gov

Summary

This study is conducted in Asia, Europe and in the United States of America. The aim of this study is to examine patient and physician beliefs regarding insulin therapy and the degree to which patients adhere to their insulin regimens.

Eligibility

Age

All ages

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•PATIENTS WITH DIABETES:
•Age 18 years or older
•Treated with insulin
•Type 1 or Type 2 diabetes
•PHYSICIANS:
•In practice for more than 1 year since completing residency
•See a minimum number of patients with diabetes per week (primary care physicians 5, specialists 10)
•Initiate insulin treatment for patients with diabetes

Locations (10)

Novo Nordisk Investigational Site

Princeton, New Jersey, United States

Novo Nordisk Investigational Site

Beijing, Beijing Municipality, China

Novo Nordisk Investigational Site

Paris La Défense Cedex, France

Novo Nordisk Investigational Site

Mainz, Germany

Novo Nordisk Investigational Site

Bangalore, India

Novo Nordisk Investigational Site

Tokyo, Japan

Novo Nordisk Investigational Site

Moscow, Russia

Novo Nordisk Investigational Site

Madrid, Spain

Novo Nordisk Investigational Site

Istanbul, Turkey (Türkiye)

Novo Nordisk Investigational Site

Crawley, United Kingdom

Key Dates

Start Date

March 1, 2010

Primary Completion Date

September 1, 2010

Completion Date

September 1, 2010

Last Updated

April 27, 2017

Enrollment

1,800

ACTUAL participants

Conditions

DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2

Interventions

No treatment given

BEHAVIORAL

survey

BEHAVIORAL

Sponsors

Lead Sponsor

Novo Nordisk A/S

Related Studies

Feasibility of a Tailored Online Self-compassion Intervention

NCT07051005

Type 1 Diabetes MellitusType 2 Diabetes Mellitus (T2DM)

Genetic Studies of Insulin and Diabetes

NCT00001987

Diabetes MellitusSevere Insulin Resistance

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 27, 2017Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions